A key finding in our study is that high EVA1C expression correlates with the high abundance of immune infiltrates including B cells, CD4+ T cells, neutrophils, macrophages and DCs in WHO grade II/III glioma. The gene discussed is EVA1C; the disease is central nervous system cancer.